prívate Singapore antibody company just raised US$125M https://hummingbirdbioscience.com/hummingbird-bioscience-raises-us125-million-in-series-c-financing/
different targets (and more of them) and not yet in clinic but has some string backers - perhaps something AD1 may be pivoting towards - the Japanese patent does suggest a Corollation to the Asia partner references that have infused recent announcements
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.225M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $6.83K | 3.415M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 7849931 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 15952546 | 18 |
View Market Depth
| Last trade - 15.58pm 29/07/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |